-
1
The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials
Published 2022-01-01Subjects: “…liraglutide…”
Get full text
Article -
2
Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
Published 2024-09-01Subjects: Get full text
Article -
3
Liraglutide and GLP-1(9–37) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3β/Nrf2 pathway and SMAD159/Hepcidin/FTH pathway
Published 2025-02-01Subjects: “…Liraglutide…”
Get full text
Article -
4
Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
Published 2025-02-01Subjects: Get full text
Article -
5
Liraglutide Effect on Weight and A1C in Patients with Type 2 Diabetes Mellitus: Real-World Data from a Single Tertiary Care Center in Saudi Arabia
Published 2024-12-01Subjects: Get full text
Article -
6
Potential benefits of GLP-1 analogues and metformin in patients with osteoarthritis
Published 2025-01-01Subjects: Get full text
Article -
7
Liraglutide alleviates high-fat diet-induced kidney injury in mice by regulating the CaMKKβ/AMPK pathway
Published 2024-12-01Subjects: “…Liraglutide…”
Get full text
Article -
8
-
9
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
Published 2024-04-01Subjects: Get full text
Article